This is a randomized, double-blind, parallel controlled, multicenter clinical trial.~The primary objective is to assess the efficacy similarity of LY09004 and EYLEA in the treatment of w-AMD.~The secondary objective is to assess the safety similarity of LY09004 and EYLEA in the treatment of w-AMD.
A randomized, double-blind, parallel controlled, multicenter clinical trial to compare the efficacy and safety of LY09004 and EYLEA in the Treatment of Wet Age-related Macular Degeneration（wAMD)